Oenon Holdings
Basic Information
- Stock Code
- 2533
- Industry
- Food
- Category Detail
- Beverages, Tobacco & Luxury Foods
- Prefecture
- Tokyo
- Establishment Year
- October 1924
- Listing Year
- May 1949
- Official Website
- https://www.oenon.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Sapporo Holdings, Asahi Group Holdings, Kirin Holdings, Takara HLD, Uoki, Mitsushi
Overview
Oenon Holdings is a major holding company founded in 1924 specializing in shochu and sake production, offering a diverse range of liquor brands and pharmaceutical raw materials, and has established a solid position in the industry.
Current Situation
Oenon Holdings achieved consolidated sales of approximately 84.1 billion yen and operating profit of approximately 3.4 billion yen for the fiscal year ending December 2024, maintaining a stable revenue base. Its core shochu and sake businesses are steadily expanding market share through regionally tailored products. It is also actively advancing bio-related businesses such as enzyme pharmaceuticals to diversify operations. Focusing on environmental conservation and regional contributions for sustainable management, it leverages multiple bases including Asahikawa in Hokkaido, Aomori, and Shizuoka for product development and production efficiency improvements. While preparing for risks such as intensifying market competition and raw material price fluctuations, it emphasizes strengthening brand power and new product development. In the medium to long term, it anticipates growth through overseas expansion and digitalization. Recently, notable initiatives include price increases for imo shochu and support for factory reconstruction through regional collaboration, reinforcing its business foundation.
Trivia
Interesting Facts
- The name Oenon derives from Oeno, the Greek goddess of wine.
- Founded in 1924 by the merger of four shochu makers in Hokkaido.
- Hokkaido-originated shiso shochu 'Takatan' is a nationwide hit.
- Strong in pharmaceutical enzyme products, advancing into the bio field.
- Traditional brand 'Denki Bran' originated in Asakusa as a liqueur.
- Subsidiary Godo Shusei operates numerous factories centered in Hokkaido.
- Diversifies business by bringing multiple sake breweries under its umbrella.
- Offers many regionally limited products with strong local market support.
- As a long-established firm from pre-war era, plays a significant historical role in the liquor industry.
- Unique labels and packaging designs have a dedicated fanbase.
- Actively develops original liquors paired with local cuisine.
- Provides OEM supply to restaurants, supporting business demand.
- Supplies medical reagents to domestic medical institutions.
- Participates as sponsor in various local community events.
- In addition to shochu and sake, developing new liquor categories.
Hidden Connections
- Realized pharmaceutical raw materialization of imo shochu through joint research with Kyushu University.
- Historical ties to the brand of Kamiya Bar dating back to the Edo period.
- Business partnerships with diverse liquor manufacturers for joint product development.
- Strong collaboration with local governments through regionally limited product rollouts.
- Deep technical cooperation with medical-related companies in pharmaceutical manufacturing division.
- Confectionery western liquor 'Neptune' enjoys longstanding trust in the confectionery industry.
- Enzyme pharmaceutical development regarded as one of Japan's bio technology pioneers.
- Extensive logistics network via multiple regional factories is a source of competitiveness.
Future Outlook
Growth Drivers
- Expansion of domestic and international demand for high-quality shochu and sake
- Growth in pharmaceutical-related products leveraging bio technology
- Customer base strengthening via regionally focused brand strategies
- Liquor development responding to health trends
- Sales channel expansion using digital marketing and e-commerce
- Enhanced product rollout in overseas markets, especially Asia
- Advancement of environmental and sustainability initiatives
- Further technological innovation in medical enzyme products
- Efficiency gains utilizing synergies within the group
- Enhanced market competitiveness through new product development
- Flexible response to changes in domestic and international drinking culture
- Risk diversification via multi-segment strategy
Strategic Goals
- Expand domestic share in liquor business and achieve over 20% overseas sales ratio
- Double sales in pharmaceutical-related business from current levels
- Achieve over 50% ratio of sustainability-certified products
- Reduce CO2 emissions by 30% in manufacturing and logistics
- Increase young customer base by 30% through strengthened digital promotion
- Advance collaboration with local communities and contributions to regional revitalization
- Maintain and expand R&D investment to over 5% of annual sales
- Shorten new product launch cycles and strengthen product lifecycle management
- Improve employee diversity and work environment
- Enhance overall group profitability and maintain financial soundness
Business Segments
Liquor Manufacturing and Sales
- Overview
- Stably supplies diverse liquors to retailers and food service industry nationwide, while implementing regionally collaborative product rollouts.
- Competitiveness
- Builds a robust sales network with regionally limited products and diversified lineup.
- Customers
-
- Retailers
- Restaurants
- Liquor Wholesalers
- Local Governments
- Local Event Organizers
- Products
-
- Various Shochu
- Various Sake
- Liqueurs
- Plum Wine
- Confectionery Western Liquor
Pharmaceuticals and Enzyme Products Manufacturing
- Overview
- Utilizes bio technology to manufacture and sell enzyme products and diagnostic drugs for the medical field.
- Competitiveness
- Development capabilities for high-quality enzyme products based on proprietary technology.
- Customers
-
- Medical Institutions
- Pharmaceutical Manufacturers
- Research Institutions
- Products
-
- Enzyme Agents
- Test Reagents
- Medical Reagents
Raw Materials Sales
- Overview
- Supports manufacturers with supplies of sake brewing raw materials and bio-related materials.
- Competitiveness
- Procurement strength for high-quality, stable raw material supply.
- Customers
-
- Liquor Manufacturers
- Food Processors
- Bio-Related Companies
- Products
-
- Liquor Raw Materials
- Starch
- Fermentation Raw Materials
Competitive Advantage
Strengths
- Proven liquor manufacturing technology
- Diversified business operations
- Regionally focused product development
- Stable financial base
- Extensive sales network via subsidiaries
- High brand recognition
- Proprietary technology for pharmaceutical enzymes
- Long history and credibility
- Diverse shochu lineup
- Strength in regionally limited products
- Continuous investment in R&D
- Business expansion through consolidated subsidiaries
- Diverse customer base
- Environmental and regional contribution activities
- Management efficiency via holding company structure
Competitive Advantages
- Strong market position of proprietary brands like Hokkaido-originated Takatan
- Growth potential in pharmaceutical-related business leveraging bio technology
- Addresses diverse customer needs with broad liquor product lineup
- Secures customer loyalty through regionally rooted product rollouts
- Flexible operations of business units enabled by holding company structure
- Diverse raw material procurement routes and quality control systems
- Long-term growth investments supported by stable revenue base
- Industry collaboration as a Kyowa Association member
- Specialized technology and R&D strength in medical reagents
- Product competitiveness from fusion of tradition and innovation
- Balanced portfolio of consumer and B2B products
- Promotion of sustainable management initiatives
- Rapid market response via specialized subsidiaries
- Enhanced sales power through multi-channel expansion
- Historical background elevating brand value
Threats
- Raw material price fluctuation risks
- Declining liquor demand due to health trends
- Sales pressure from domestic population decline
- Intensifying price competition with rivals
- Impacts from regulatory tightening or tax changes
- Production site risks from disasters
- Revenue instability from exchange rate fluctuations
- Political and economic risks in export markets
- Consumer trend away from alcohol
- Technology succession issues due to successor shortages
- Low brand awareness in emerging markets
- Cost increases from stricter environmental regulations
Innovations
2024: Co-development of Imo Shochu 'Imo Ku'
- Overview
- Developed sweet potato shochu for pharmaceutical raw materials in collaboration with Kyushu University Graduate School of Agriculture.
- Impact
- Successfully commercialized research outcomes for differentiation.
2023: Introduction of Shochu Production Efficiency Technologies
- Overview
- Introduced latest distillation equipment and production management systems to improve efficiency.
- Impact
- Contributes to cost reduction and quality uniformity.
2022: Enhanced R&D for New Enzyme Pharmaceuticals
- Overview
- Advanced basic research and practical application at the Enzyme Pharmaceutical Research Institute.
- Impact
- Expands product line in medical diagnostic drugs.
2021: Introduction of Low-Environmental-Impact Manufacturing Processes
- Overview
- Updated energy-saving equipment and wastewater treatment technology in factories.
- Impact
- Reduces environmental load and improves CSR evaluation.
2020: Launch of Digital Marketing Initiatives
- Overview
- Utilized SNS and online sales sites to expand brand online awareness.
- Impact
- Successfully acquired younger customers.
Sustainability
- Promotion of local production for local consumption through strengthened ties with Hokkaido and regional industries
- Investment in energy-saving equipment considerate of the environment
- Waste reduction activities in liquor production processes
- Sponsorship of regional events and cultural activities
- Expansion of sustainable agricultural raw material procurement
- Local job creation and human resource development programs
- Strengthened quality control in pharmaceutical manufacturing
- Compliance with environmental laws and process improvements
- Disaster support activities in collaboration with local communities
- Employee health and welfare enhancement programs
- Promotion of eco-packaging adoption
- Establishment of energy-saving logistics systems